REVIEW ARTICLES

Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review

Dimitrios Schizas, Aikaterini Mastoraki, George Bagias, Raphael Patras, Dimitrios Moris, Ioannis I. Lazaridis, Nikolaos Arkadopoulos, Evangelos Felekouras; pp 415-423 (Pubmed Abstract, PDF)

Advanced treatment in high-grade gliomas

Lai Xiong, Feng Wang, Xiao Qi Xie; pp 424-430 (Pubmed Abstract, PDF)

ORIGINAL ARTICLES

COLORECTAL CANCER

Outcomes of surgical management of iatrogenic colonic perforation by colonoscopy and risk factors for worse outcome

Audrius Dulskas, Edgaras Smolskas, Inga Kildusiene, Romualdas Maskelis, Eugenijus Stratilatovas, Povilas Miliauskas, Renatas Tikuisis, Narimantas E. Samalavicius; pp 431-435 (Pubmed Abstract, PDF)

Analysis of risk factors for concurrent pulmonary infection after operation for colon cancer

Lei Jin, Xiaochun Zhang, Lin Deng, Wei Wu, Wanjin Shao, Lixin Yin, Ruohan Lin; pp 436-441 (Pubmed Abstract, PDF)

The short-term effect analysis of intraoperative intraperitoneal perfusion chemotherapy with lobaplatin for colorectal cancer

Hai-Tao Zhou, Jun Jian, Xu Guan, Hao Su, Jian-Wei Liang, Wei Pei, Zheng Wang, Zheng Liu, Zheng Jiang, Qian Liu, Zhi-Xiang Zhou, Wei-Sen Jin, Xi-Shan Wang; pp 442-448 (Pubmed Abstract, PDF)

Effect of TGF-β1 on apoptosis of colon cancer cells via the ERK signaling pathway 

Yunshan Zhao, Shaoyou Xia, Chen Cao, Xiaohui Du; pp 449-455 (Pubmed Abstract, PDF)

Clinical value of significance of Hypoxia Inducible Factor-1α, Glucose Transporter-1 and Carbonic Anhydrase IX in rectal cancer after preoperative chemoradiotherapy

Dimitra – Irinna Vitoratou, Maria Tolia, Panagiotis Liakos, Nikolaos Tsoukalas, Constantinos Giaginis, Michail Nikolaou, Georgios Nikolaou, Georgios Rigas, Kyriakos Psarianos, Athanassios Lioupis, George Kyrgias; pp 456-463 (Pubmed Abstract, PDF)

Comparison of perioperative clinicopathologic outcome and postoperative survival of laparoscopic and open sphincter-sparing surgery in patients with rectal cancer: a retrospective study

Zhanzhi Zhang, Benqiang Rao, Zhipeng Sun, Nengwei Zhang; pp 464-469 (Pubmed Abstract, PDF)

Differential effect of concurrent chemotherapy regimen on clinical outcomes of preoperative chemoradiotherapy for locally advanced rectal cancers

Eunji Kim, Kyubo Kim, Do Hoon Oh, Sae-Won Han, Tae-You Kim, Seung-Yong Jung, Kyu Joo Park, Gyeong Hoon Kang, Eui Kyu Chie; pp 470-478 (Pubmed Abstract, PDF)

The impact of primary tumor localization on survival and treatment outcomes in patients with metastatic colorectal cancer-a multicenter study

Suleyman Sahin, Fatih Karatas; pp 479-487 (Pubmed Abstract, PDF)

Apigenin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant colon cancer cells by inducing autophagy, programmed cell death and targeting m-TOR/PI3K/Akt signalling pathway

Xiaping Chen, Hang Xu, Xinhua Yu, Xue Wang, Xiaohu Zhu, Xiaofeng Xu; pp 488-493 (Pubmed Abstract, PDF)

Efficacy and adverse reactions of combination therapy of bevacizumab and 5-fluorouracil in patients with metastatic colon cancer

Xinyi Zhou, Jianqiang Jin, Weijia Wang, Yuan Yin, Yankui Liu, Yan Qin, Xiaowei Qi; pp 494-500 (Pubmed Abstract, PDF)

BREAST CANCER

Circular RNA-100219 promotes breast cancer progression by binding to microRNA-485-3p

Yongqiang Yao, ZiweiZhao, Xue Han, Shan Lin, Chen Nie, Hong Fang; pp 501-508 (Pubmed Abstract, PDF)

The diagnostic value of MRI multi-parameter combination for breast lesions with ring enhancement

Mingfeng Niu, Xingwen Huang, Qiang Yin; pp 509-515 (Pubmed Abstract, PDF)

Do we really know how to overcome trastuzumab resistance in hormone sensitive metastatic breast cancer?

Ana Cvetanovic, Ivica Pejcic, Nikola Zivkovic, Dane Krtinic, Milos Kostic, Lazar Popovic; pp 516-521 (Pubmed Abstract, PDF)

Efficacy of neoadjuvant chemotherapy and Annexin A3 expression in breast cancer

Shiguang Zhu, Yalun Li, Yidan Wang, Jianqiao Cao, Xiaohui Li, Ji Wang,Xingmiao Wang; pp 522-528 (Pubmed Abstract, PDF)

Evaluation of sleep pattern disorders in breast cancer patients receiving adjuvant treatment (chemotherapy and/or radiotherapy) using polysomnography

El-Sayed Tag Eldin, Samar galal Younis, Lamiss Mohamed Abd El Aziz, Amr Tag Eldin, Sherif Tarek Erfan; pp 529-534 (Pubmed Abstract, PDF)

LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer

Jiaqi Yan, Rui Wang, Zhiyong Wu; pp 535-542 (Pubmed Abstract, PDF)

Surgery in initially metastatic breast cancer: prognosis is associated with patient characteristics and timing of surgery

Faling Xue, Liang Yu, Ying Lin, Zhongxing Wang, Songqi Li, Nan Shao, Fang Ye, Chen Gu, Xiaoxi Li; pp 543-548 (Pubmed Abstract, PDF)

Root extract of Prunella vulgaris inhibits in vitro and in vivo carcinogenesis in MCF-5 human breast carcinoma cells via suppression of angiogenesis, induction of apoptosis, cell cycle arrest and modulation of PI3K/AKT signalling pathway

Wei Gao, Hua Liang, Yanlei Li, Yuanyuan Liu, Yanxia Xu; pp 549-554 (Pubmed Abstract, PDF)

Value of tissue elastography in the prediction of efficacy of neoadjuvant chemotherapy in breast cancer

Chao Fang, Tingting Wu, Yingying Zhou, Jun Xue, Weiwei Yang; pp 555-559 (Pubmed Abstract, PDF)

LUNG CANCER

Aclidinium Bromide holds promising inhibitory effects in A549 lung cancer cells potentials by regulating PI3K / AKT signaling pathway 

Gang Lin, Yu He, Dongmei Han, Dan Shi, Tao Liu, Yuting Gao, Wei Guan, Guanghui Cheng; pp 560-565 (Pubmed Abstract, PDF)

Linderalactone inhibits human lung cancer growth by modulating the expression of apoptosis-related proteins, G2/M cell cycle arrest and inhibition of JAK/STAT signalling pathway

Yanglin Deng, Ya Li; pp 566-571 (Pubmed Abstract, PDF)

Effect of preoperative infusion chemotherapy combined with hyperthermia on sPD-L1 and CEA levels and overall survival of elderly patients undergoing radical resection of lung cancer

Leilei Zhou, Tiecheng Zhang, Yuan Sun, Ruihua Fan, Lijuan Xu, Shun Yue, Rong Yao; pp 572-577 (Pubmed Abstract, PDF)

Clinical research on stereotactic radiosurgery combined with epithermal growth factor tyrosine kinase inhibitors in the treatment of brain metastasis of non-small cell lung cancer

Feng Jia, Xiangming Cheng, Hongsheng Zeng, Juncheng Miao,Meiying Hou; pp 578-584 (Pubmed Abstract, PDF)

Correlations of coagulation indexes and inflammatory changes with the prognosis of lung cancer complicated with thromboembolic disease

Minfeng Zhu, Yi Dai, Feng Gao, Chunming Xu, Lixiu Chen, Yun Xu, Wenxia Qian; pp 585-590 (Pubmed Abstract, PDF)

MicroRNA-203 promotes the malignant progression of non-small cell lung cancer via survivin

Zongwu Li, Yuanfang Li, Yueyong Wang; pp 591-598 (Pubmed Abstract, PDF)

Exosomal miR-660-5p promotes tumor growth and metastasis in non-small cell lung cancer

Yongjian Qi, Wangjian Zha, Wei Zhang; pp 599-607 (Pubmed Abstract, PDF)

HEPATOCELLULAR CARCINOMA

Clinical efficacy of TACE combined with Apatinib in the treatment of advanced hepatocellular carcinoma

Yuxia Zhu, Bo Feng, Lin Mei, Ruiqing Sun, Changcun Guo, Jiangyi Zhu; pp 608-614 (Pubmed Abstract, PDF)

Clinical efficacy of DC-CIK combined with sorafenib in the treatment of advanced hepatocellular carcinoma

Zhao Zhou, Hui Qin, Lixin Weng, Yijiang Ni; pp 615-621 (Pubmed Abstract, PDF)

Tanshindiol-C suppresses in vitro and in vivo hepatocellular cancer cell growth by inducing mitochondrial-mediated apoptosis, cell cycle arrest, inhibition of angiogenesis and modulation of key tumor-suppressive miRNAs

Ping Zhou, Yunzhou Cheng, Fangli Liu, Kai Wu, Weilong Qiu, Shouqi Wang; pp 622-627 (Pubmed Abstract, PDF)

Effect of puerarin on apoptosis of human hepatocellular carcinoma cells under oxidative stress and its mechanisms

Zhen Wu, Shifeng Kan, Chunfeng Li, Xin Lu; pp 628-633 (Pubmed Abstract, PDF)

Decreased expression of Beclin-1 in patients with hepatocellular carcinoma 

Haiying Sun, Jun Yu, Zirong Wen, Mingmin Wang, Wenmei Chen; pp 634-641 (Pubmed Abstract, PDF)

Comparison of TACE combined with and without iodine-125 seeds implantation therapy for advanced stage hepatocellular carcinoma: a systematic review and meta-analysis

Qiang Liu, Xiang-cheng Dai, Xiao-lin Zhou, Feng Ye, Yuan-hong Zhou; pp 642-649 (Pubmed Abstract, PDF)

GASTRIC CANCER

Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group

Ali Murat Sedef, Fatih Kose, Ahmet Taner Sumbul,Ali Ayberk Besen, Bekir Hacioglu, Meral Gunaldi, Erdinc Nayir, Ozgur Tanriverdi, Erkan Arpaci, Huseyin Abali, Ozgur Ozyilkan; pp 650-655 (Pubmed Abstract, PDF)

Low expression of lncRNA NBAT-1 promotes gastric cancer development and is associated with poor prognosis

Yuan Gao, Jianping Chen; 656-662 (Pubmed Abstract, PDF)

Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients

Chen Xu, Hongli Cui, Huazhi Li, Yongzhe Wu, Hongchao An, Chunhai Guo; 663-671 (Pubmed Abstract, PDF)

Clinicopathological characteristics, prognosis and survival outcome of gastric cancer in young patients: A large cohort retrospective study

Kemal Tekesin, Mehmet Emin Gunes, Deniz Tural, Emre Akar, Alisan Zirtiloglu, Mustafa Karaca, Fatih Selcukbiricik, Savas Bayrak, Ahmet Ozet; 672-678 (Pubmed Abstract, PDF)

Prognostic analysis of gastric mucosal dysplasia after endoscopic resection: A single-center retrospective study

Leyao Zhang, Hui Wang; pp 679-685 (Pubmed Abstract, PDF)

Totarol, a natural diterpenoid, induces selective antitumor activity in SGC-7901 human gastric carcinoma cells by triggering apoptosis, cell cycle disruption and suppression of cancer cell migration

Tong Xu, Lunhua Huang, Zhiqiang Liu, Dongwen Ma, Guowei Zhang, Xiaofei Ning, Xinyang Lu, Hongsheng Liu,Biao Jiang; pp 686-692 (Pubmed Abstract, PDF)

Impact of skip lymph node metastasis on the prognosis of gastric cancer patients who underwent curative gastrectomy

Bochao Zhao, Di Mei, Jiale Zhang, Rui Luo, Huiwen Lu, Huimian Xu, Baojun Huang; pp 693-700 (Pubmed Abstract, PDF)

GYNECOLOGICAL CANCER

L-Tetrahydropalmatine enhances the sensitivity of human ovarian cancer cells to cisplatin via microRNA-93/PTEN/Akt cascade

Jian Gong, Chao Xing, Lian-yun Wang, Shuang-shuang Xie, Wen-dong Xiong; 701-708 (Pubmed Abstract, PDF)

Inhibition of in vitro and in vivo ovarian cancer cell growth by pinoresinol occurs by way of inducing autophagy, inhibition of cell invasion, loss of mitochondrial membrane potential and inhibition Ras/MEK/ERK signalling pathway 

Yang Ning,Yue ling Fu,Qing Hua Zhang,Chun Zhang, Ying Chen; pp 709-714 (Pubmed Abstract, PDF)

RCD24, B7-H4 and PCNA expression and clinical significance in ovarian cancer

Cui Zheng, Ru Yang; pp 715-719 (Pubmed Abstract, PDF)

Molecular mechanism and role of NF-κB in the early diagnosis of cervical cancer

Fu Hua, Chang-hua Li, Ying-chun Gao, Ji Li, Fei Meng; pp 720-728 (Pubmed Abstract, PDF)

PANCREATIC CANCER

LINC00339 promotes cell proliferation and metastasis in pancreatic cancer via miR-497-5p/IGF1R axis

Renchun Zhang, Shuqing Hao, Lei Yang, Jiemei Xie, Shulin Chen, Guiqin Gu; pp 729-738 (Pubmed Abstract, PDF)

A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway

Baoyu Li, Jingbo Yang,Zenghong Lu, Bin Liu, Fangzhou Liu; pp 739-745 (Pubmed Abstract, PDF)

Aloe emodin exerts potent anticancer effects in MIAPaCa-2 and PANC-1 human pancreatic adenocarcinoma cell lines through activation of both apoptotic and autophagic pathways, sub-G1 cell cycle arrest and disruption of mitochondrial membrane potential (ΛΨm)

Yiqun Du, Jian Zhang, Zhonghua Tao, Chenchen Wang, Shiyan Yan, Xiaowei Zhang, Mingzhu Huang; pp 746-753 (Pubmed Abstract, PDF)

HEMATOLOGICAL MALIGNANCIES

Role of prophylactic radiotherapy in Chinese patients with primary testicular diffuse large B-cell lymphoma: a single retrospective study

Jiadai Xu, Yang Ke, Yian Zhang, Chen Chen, Jing Li, Zheng Wei, Peng Liu; pp 754-762 (Pubmed Abstract, PDF)

Long non-coding RNA H19 promotes proliferation of Hodgkin’s lymphoma via AKT pathway

Yan Wang, Li Wang, Minghua Sui; pp 763-769 (Pubmed Abstract, PDF)

NETs

Primary peripheral neuroectodermal tumor (PNET) of the adrenal gland: a rare entity

Nektarios Koufopoulos, Stefania Kokkali, Dimitrios Manatakis, Dimitrios Balalis, Despoina Nasi, Alexandros Ardavanis, Dimitrios Korkolis, Lubna Khaldi; pp 770-778 (Pubmed Abstract, PDF)

Programmed cell death ligand- 1 expression in gastroenteropancreatic neuroendocrine tumors

Esin Oktay, Gizem Donmez Yalcin, Sumeyye Ekmekci, Dudu Solakoglu Kahraman, Abdullah Yalcin, Mustafa Degirmenci, Ahmet Dirican, Zeynep Altin, Ozlem Ozdemir, Zeki Surmeli, Gulden Diniz, Semin Ayhan, Gulcan Bulut, Atike Erdogan, Ruchan Uslu; pp 779-790 (Pubmed Abstract, PDF)

BLADDER CANCER

Expression of mir-143 in serum of bladder cancer patients and its correlation with clinical features and prognosis  

Xigao Liu, Wei Zhao, Xin Wang, Yaofeng Zhu, Zunlin Zhou, Benkang Shi; pp 791-796 (Pubmed Abstract, PDF)

miR-19a promotes invasion and epithelial to mesenchymal transition of bladder cancer cells by targeting RhoB

Zongwu Li, Yuanfang Li, Yueyong Wang; pp 797-804 (Pubmed Abstract, PDF)

ESOPHAGEAL CANCER

Highly expressed microRNA-124 inhibits migration and promotes apoptosis of esophageal cancer cells by degrading PDCD6

Shanliang Hu, Rukun Zang, Yang Wang, Yingchao Liang, JunjunMu, Yang Zhang, Jinbo Ma; pp 805-812 (Pubmed Abstract, PDF)

THYROID CANCER

Analysis of risk factors for postoperative recurrence of thyroid cancer

Xianyang Luo, Aimin Chen, Yi Zhou, Yuanqin Jiang, Binghuang Zhang, Jinpeng Wu; pp 813-818 (Pubmed Abstract, PDF)

MELANOMA

MicroRNA-29c induces G1 arrest of melanoma by targeting CDK6

Huan Yang, Chunhua Shen; pp 819-826 (Pubmed Abstract, PDF)

OSTEOSARCOMA

Therapeutic effects of adriamycin combined with high-intensity focused ultrasound on osteosarcoma

Chunqiu Wang; pp 826-831 (Pubmed Abstract, PDF)

PROSTATE CANCER

Distributions and characteristics of initial PSA and PSA velocity in Chinese men aged 50 years and younger without prostate cancer: a multi-center study

Wenjun Yang, Sirong Liu, Cheng Hu, Keji Xie, Xinghua Wei, Weiwei Zeng, Ping Tang; pp 832-837 (Pubmed Abstract, PDF)

RADIOTHERAPY

A dosimetric comparison between volumetric-modulated arc therapy and dynamic conformal arc therapy in SBRT

Sotirios Stathakis, Ganesh Narayanasamy, Anna Laura Licon, Pamela Myers, Ying Li, Richard Crownover, Niko Papanikolaou; pp 838-843 (Pubmed Abstract, PDF)

MISCELLANEOUS

Improved delivery of doxorubicin by altering the tumor microenvironment using ultrasound combined with microbubbles and chemotherapy

Nina Xiao, Jianhua Liu, Lianlian Liao, Jimei Sun, Wenhui Jin, Xian Shu; pp 844-852 (Pubmed Abstract, PDF)

Taxifolin inhibits the scar cell carcinoma growth by inducing apoptosis, cell cycle arrest and suppression of PI3K/AKT/mTOR pathway 

Wei Zhou, Zeming Liu, Min Wang, Danyang Chen, Ling Zhou, Liang Guo; pp 853-858 (Pubmed Abstract, PDF)

COMMENTARY

Is Phosphorus the “Key” of cancer?

Vassilis Kouloulias, Christos-David Papaloucas, Aristofanis Papaloucas; pp 859-861 (Pubmed Abstract, PDF)

LETTERS TO THE EDITOR

Combined use of vitamin D and omega-3 fatty acid in breast cancer patients might be more beneficial for reducing aromatase inhibitors-associated arthralgia

Kadri Altundag; p 862 (Pubmed Abstract, PDF)

Primary pulmonary follicular dendritic cell sarcoma: Successful treatment of an extremely rare case 

Fatmir Caushi, Leart Berdica, Daniela Xhemalaj, Ilir Skenduli; p 862 (Pubmed Abstract, PDF)

BRAF mutations in oral malignancies 

Vasileios S.Papanikolaou, Efthymios Kyrodimos, Evangelos Tsiambas, Aristeidis Chrysovergis; p 863 (Pubmed Abstract, PDF)

De-escalating systemic chemotherapy might be considered for pure triple negative apocrine breast cancer patients

Kadri Altundag; p 864 (Pubmed Abstract, PDF)

Bcl-2 as a target in laryngeal squamous cell carcinoma

Nicholas S. Mastronikolis,Evangelos Tsiambas, Panagiotis P. Fotiades, Vasileios Ragos; p 865 (Pubmed Abstract, PDF)

Amazing result of Nivolumab in a patient with multiple carcinoma

Stefano Manno, Antonio Cicione, Lucio Dell’Atti, Teresa Del Giudice; p 865 (Pubmed Abstract, PDF)

The importance of regorafenib and lenvatinib in the treatment of hepatocellular carcinoma

Yasemin Benderli Cihan; pp 866-867 (Pubmed Abstract, PDF)

HISTORY OF ONCOLOGY

Rhazes’ (864-925) views on cancer and the introduction of
chemotherapy

Gregory Tsoucalas , Marianna Karamanou, Konstantinos Laios, George Androutsos; pp 868-871 (Pubmed Abstract, PDF)

Author: Andy Athns